Jun 22, 2020
Lantheus Completes Merger with Progenics
Jun 18, 2020
Global Endometriosis Market and Competitive Landscape to 2024
May 28, 2020
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 12, 2020
Global Hypogonadism Market Insights, 2016-2024: Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares
Apr 30, 2020
SAGE-217 Product Insights, 2020-2028: Mechanism of Action, Dosage & Administration, Route of Synthesis, Research & Developments, Future Market Assessments
Apr 28, 2020
Relmada Therapeutics Enhances Senior Leadership Team with Appointment of Brian A. Walter, Ph.D., as Vice President of Regulatory Affairs
Mar 31, 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Mar 26, 2020
2020 Analysis on the Hydrocodone Bitartrate Industry - Trends & Developments, Major Players, Patents and More
Mar 25, 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea® from Oasmia Pharmaceutical
Mar 24, 2020
Relmada Therapeutics Strengthens Scientific Leadership Team with the Appointment of Judy Caron, Ph.D., as Vice President of Drug Development
Feb 11, 2020
Lipocine Streamlines Its Infringement Lawsuit Against Clarus Therapeutics
Jan 31, 2020
Lilly's REYVOW(TM) (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription
Jan 08, 2020
BayMark Health Services Opioid Treatment Programs Nationwide Now Accept Medicare
Jan 06, 2020
Original Medicare patients living with opioid use disorder are fully covered at all BHG Centers as of January 1, 2020
Jan 01, 2020
Global & Chinese Lobeline hydrochloride Market Insights 2019: Analysis and Forecast 2019-2024 - ResearchAndMarkets.com
Dec 23, 2019
Auburn's Harrison School of Pharmacy establishes Center for Opioid Research, Education and Outreach
Dec 17, 2019
PTCB Funds Anti-Opioid Abuse Projects Including Naloxone Training for Pharmacy Technicians
Dec 11, 2019
FDA issues warning letter for not including the most serious risks in advertisement for medication-assisted treatment drug
Dec 11, 2019
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA
Dec 09, 2019
The ketone market is projected to grow at a CAGR of 6.3% from 2019 to 2025